With 500,000 euros, the Fondation Charcot Stichting provides the essential resources for 10 teams of experienced researchers in neurology, neuroimmunology, neurobiology and rehabilitation sciences to ensure innovative and concrete advances in multiple sclerosis research.
Multiple sclerosis is a chronic inflammatory disease of the central nervous system that affects over two million people worldwide. Patients may suffer from a wide range of disabling complaints which are not always easy to treat. Although cannabis is best known as a psychoactive recreational drug, it is also increasingly associated with a variety of positive medical effects.
Multiple sclerosis is the commonest neurological disease affecting young adults. In patients under 30, treatment needs to be adjusted accordingly.
The two major research pathways that could change the future of people with multiple sclerosis, confirm themselves and a life where MS becomes a treatable and controllable condition comes a step closer.
There are many ways to support research: on the occasion of a wedding, a birthday, a neighbors' party, a BBQ, being sponsored during a race or a walk. It's all up to you: our "Action" platform is waiting for you here.
The 104 runners of the Charcot team of the 20 k - Brussels 2019, set an example: together they raised enough money to fund 155 days of research in multiple sclerosis! The next edition of the 20 km will take place on May 31, 2020 and registration will begin on December 15, 2019.
